38
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Improving Mental Health Outcomes in Patients with Major Depressive Disorder in the Gulf States: A Review of the Role of Electronic Enablers in Monitoring Residual Symptoms

, , , , ORCID Icon &
Pages 3341-3354 | Received 22 Apr 2024, Accepted 27 Jun 2024, Published online: 11 Jul 2024

References

  • Alzahrani O. Depressive disorders in the Arabian Gulf Cooperation Council countries: a literature review. J Int Med Res. 2020;48(10):300060520961917. doi:10.1177/0300060520961917
  • World Health Organization. Depression and other common mental disorders. Global health estimates. Available from: https://iris.who.int/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf?sequence=1. Accessed October 1, 2023.
  • Rameez S, Nasir A. Barriers to mental health treatment in primary care practice in low- and middle-income countries in a post-covid era: a systematic review. J Family Med Prim Care. 2023;12(8):1485–1504. doi:10.4103/jfmpc.jfmpc_391_22
  • Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559–568. doi:10.1056/NEJMcp1712493
  • Wang Y, Wang G, Zhang N, et al. Association between residual symptoms and social functioning in patients with depression. Compr Psychiatry. 2020;98:152164. doi:10.1016/j.comppsych.2020.152164
  • Fagiolini A, Cardoner N, Pirildar S, et al. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. Expert Opin Pharmacother. 2023;24(15):1715–1723. doi:10.1080/14656566.2023.2242264
  • Al-Shannaq Y, Jaradat D, Ta’an WF, Jaradat D. Depression stigma, depression literacy, and psychological help seeking attitudes among school and university students. Arch Psychiatr Nurs. 2023;46:98–106. doi:10.1016/j.apnu.2023.08.010
  • Musa A, Ashraf J, Tsai FJ, et al. Depression severity and depression stigma among students: a survey of universities in five countries. J Nerv Ment Dis. 2020;208(11):884–889. doi:10.1097/NMD.0000000000001226
  • Dubreucq J, Plasse J, Franck N. Self-stigma in serious mental illness: a systematic review of frequency, correlates, and consequences. Schizophr Bull. 2021;47(5):1261–1287. doi:10.1093/schbul/sbaa181
  • Montano CB, Jackson WC, Vanacore D, Weisler R. Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression. Postgrad Med. 2023;135(5):449–465. doi:10.1080/00325481.2023.2189868
  • Duffy L, Lewis G, Marston L, et al. Clinical factors associated with relapse in depression in a sample of UK primary care patients who have been on long-term antidepressant treatment. Psychol Med. 2023;53:1–11. doi:10.1017/S0033291722003981
  • Alkaabi AJ, Alkous A, Mahmoud K, et al. The prevalence and correlates of depression among patients with chronic diseases in the United Arab Emirates. PLoS One. 2022;17(12):e0278818. doi:10.1371/journal.pone.0278818
  • Salinas-Perez JA, Ghuloum S, Gutierrez-Colosia MR, Bagheri N, Salvador-Carulla L. Analysis of the mental health service provision in Qatar: progressing in community mental health in a Middle East country. Front Psychiatry. 2022;13:1095788. doi:10.3389/fpsyt.2022.1095788
  • Andrade G, Bedewy D, Elamin ABA, Abdelmonem KYA, Teir HJ, Alqaderi N. Attitudes towards mental health problems in a sample of United Arab Emirates’ residents. Middle East Curr Psychiatry. 2022;29:88. doi:10.1186/s43045-022-00255-4
  • Welch KG, Faria I, Browder SE, Drudi LM, McGinigle KL. Depression in patients with peripheral artery disease: an underdiagnosis with increased mortality. Ann Vasc Surg. 2023;95:80–86. doi:10.1016/j.avsg.2023.03.002
  • Pettersson A, Modin S, Wahlstrom R, Af Winklerfelt Hammarberg S, Krakau I. The mini-international neuropsychiatric interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: a mixed-methods study. BMC Fam Pract. 2018;19(1):19. doi:10.1186/s12875-017-0674-5
  • Collins B, Downing J, Head A, Cornerford T, Nathan R, Barr B. Investigating the impact of undiagnosed anxiety and depression on health and social care costs and quality of life: cross-sectional study using household health survey data. BJPsych Open. 2023;9(6):e201. doi:10.1192/bjo.2023.596
  • Chodavadia P, Teo I, Poremski D, Fung DSS, Finkelstein EA. Prevalence and economic burden of depression and anxiety symptoms among Singaporean adults: results from a 2022 web panel. BMC Psychiatry. 2023;23(1):104. doi:10.1186/s12888-023-04581-7
  • Papalexi E, Galanopoulos A, Roukas D, et al. Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD). J Affect Disord. 2022;314:185–192. doi:10.1016/j.jad.2022.07.009
  • Vicent-Gil M, Serra-Blasco M, Navarra-Ventura G, et al. In pursuit of full recovery in major depressive disorder. Eur Arch Psychiatry Clin Neurosci. 2023;273(5):1095–1104. doi:10.1007/s00406-022-01487-5
  • Sumiyoshi T, Hoshino T, Mishiro I, et al. Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder. J Affect Disord. 2022;296:95–102. doi:10.1016/j.jad.2021.09.025
  • Nierenberg AA. Residual symptoms in depression: prevalence and impact. J Clin Psychiatry. 2015;76(11):e1480–e1480. doi:10.4088/JCP.13097TX1C
  • Jackson WC, Papakostas GI, Rafeyan R, Trivedi MH. Recognizing inadequate response in patients with major depressive disorder. J Clin Psychiatry. 2020;81(3). doi:10.4088/JCP.OT19037BR2
  • Pitanupong J, Sathaporn K, Tepsuan L. Residual symptoms and their associated factors among Thai patients with depression: a multihospital-based survey. Ann Gen Psychiatry. 2022;21(1):50. doi:10.1186/s12991-022-00427-w
  • McIntyre RS, Agid O, Biesheuvel E, Purushottamahanti P. Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. CNS Spectr. 2024;29(3):206–214. doi:10.1017/S1092852924000245
  • Park IH, Lee BC, Kim JJ, Kim JI, Koo MS. Effort-based reinforcement processing and functional connectivity underlying amotivation in medicated patients with depression and schizophrenia. J Neurosci. 2017;37(16):4370–4380. doi:10.1523/JNEUROSCI.2524-16.2017
  • Yuen GS, Bhutani S, Lucas BJ, et al. Apathy in late-life depression: common, persistent, and disabling. Am J Geriatr Psychiatry. 2015;23(5):488–494. doi:10.1016/j.jagp.2014.06.005
  • Korte SM, Prins J, Krajnc AM, et al. The many different faces of major depression: it is time for personalized medicine. Eur J Pharmacol. 2015;753:88–104. doi:10.1016/j.ejphar.2014.11.045
  • Fervaha G, Foussias G, Takeuchi H, Agid O, Remington G. Motivational deficits in major depressive disorder: cross-sectional and longitudinal relationships with functional impairment and subjective well-being. Compr Psychiatry. 2016;66:31–38. doi:10.1016/j.comppsych.2015.12.004
  • Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res. 1991;38(2):143–162. doi:10.1016/0165-1781(91)90040-V
  • Da Silva S, Saperia S, Siddiqui I, et al. F255. Motivation system impairment profiles in schizophrenia and major depressive disorder. Biol Psychiatry. 2018;83:S338. doi:10.1016/j.biopsych.2018.02.869
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. DSM-5-TRTM. American Psychiatric Association; 2022.
  • Su YA, Si T. Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. Gen Psychiatr. 2022;35(1):e100724. doi:10.1136/gpsych-2021-100724
  • De Fruyt J, Sabbe B, Demyttenaere K. Anhedonia in depressive disorder: a narrative review. Psychopathology. 2020;53(5–6):274–281. doi:10.1159/000508773
  • Shankman SA, Katz AC, DeLizza AA, Sarapas C, Gorka SM, Campbell ML. The different facets of anhedonia and their associations with different psychopathologies. In: Ritsner MS, editor. Anhedonia: A Comprehensive Handbook Volume I: Conceptual Issues and Neurobiological Advances. Dordrecht: Springer Netherlands; 2014:3–22.
  • Argyropoulos SV, Nutt DJ. Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? J Psychopharmacol. 2013;27(10):869–877. doi:10.1177/0269881113494104
  • Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009;195(3):211–217. doi:10.1192/bjp.bp.108.051110
  • Serretti A. Anhedonia and depressive disorders. Clin Psychopharmacol Neurosci. 2023;21(3):401–409. doi:10.9758/cpn.23.1086
  • Kennedy SH, Lam RW, Rotzinger S, et al. Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients with major depressive disorder: a CAN-BIND-1 report. J Clin Psychiatry. 2019;80(2). doi:10.4088/JCP.18m12202
  • Hammond MF. Rating depression severity in the elderly physically ill patient: reliability and factor structure of the Hamilton and the Montgomery-Asberg depression rating scales. Int J Geriatr Psychiatry. 1998;13(4):257–261. doi:10.1002/(SICI)1099-1166(199804)13:4<257::AID-GPS773>3.0.CO;2-U
  • Cao B, Park C, Subramaniapillai M, et al. The efficacy of vortioxetine on anhedonia in patients with major depressive disorder. Front Psychiatry. 2019;10:17. doi:10.3389/fpsyt.2019.00017
  • Parker RD, Flint EP, Bosworth HB, Pieper CF, Steffens DC. A three-factor analytic model of the MADRS in geriatric depression. Int J Geriatr Psychiatry. 2003;18(1):73–77. doi:10.1002/gps.776
  • Larson S, Nemoianu A, Lawrence DF, et al. Characterizing primary care for patients with major depressive disorder using electronic health records of a US-based healthcare provider. J Affect Disord. 2022;300:377–384. doi:10.1016/j.jad.2021.12.096
  • Uomoto KE. Increasing identification and follow-up of older adult depression in primary care. J Prim Care Community Health. 2023;14:21501319231152758. doi:10.1177/21501319231152758
  • Pinaka O, Gioulekas F, Routa E, et al. Introducing new paths towards public primary healthcare services in Greece: efforts for scaling-up mental healthcare services addressed to older adults. Healthcare. 2022;10(7). doi:10.3390/healthcare10071230
  • Javed A, Lee C, Zakaria H, et al. Reducing the stigma of mental health disorders with a focus on low- and middle-income countries. Asian J Psychiatr. 2021;58:102601. doi:10.1016/j.ajp.2021.102601
  • McIntyre RS, Ismail Z, Watling CP, et al. Patient-reported outcome measures for life engagement in mental health: a systematic review. J Patient Rep Outcomes. 2022;6(1):62. doi:10.1186/s41687-022-00468-5
  • O’Connor EA, Perdue LA, Coppola EL, Henninger ML, Thomas RG, Gaynes BN. Depression and suicide risk screening: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;329(23):2068–2085. doi:10.1001/jama.2023.7787
  • Costantini L, Pasquarella C, Odone A, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. J Affect Disord. 2021;279:473–483. doi:10.1016/j.jad.2020.09.131
  • Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev. 2016;65:21–35. doi:10.1016/j.neubiorev.2016.03.004
  • Nakonezny PA, Morris DW, Greer TL, et al. Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder. J Psychiatr Res. 2015;65:124–130. doi:10.1016/j.jpsychires.2015.03.010
  • Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological Treatments. Can J Psychiatry. 2016;61(9):540–560. doi:10.1177/0706743716659417
  • Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 2015;172:96–102. doi:10.1016/j.jad.2014.10.010
  • Chin T, Huyghebaert T, Svrcek C, Oluboka O. Individualized antidepressant therapy in patients with major depressive disorder: novel evidence-informed decision support tool. Can Fam Physician. 2022;68(11):807–814. doi:10.46747/cfp.6811807
  • Squires M, Tao X, Elangovan S, et al. Deep learning and machine learning in psychiatry: a survey of current progress in depression detection, diagnosis and treatment. Brain Inform. 2023;10(1):10. doi:10.1186/s40708-023-00188-6
  • Kaywan P, Ahmed K, Ibaida A, Miao Y, Gu B. Early detection of depression using a conversational AI bot: a non-clinical trial. PLoS One. 2023;18(2):e0279743. doi:10.1371/journal.pone.0279743
  • Farhat F. ChatGPT as a complementary mental health resource: a boon or a bane. Ann Biomed Eng. 2023;2023:1.
  • Tutun S, Johnson ME, Ahmed A, et al. An AI-based decision support system for predicting mental health disorders. Inf Syst Front. 2023;25(3):1261–1276. doi:10.1007/s10796-022-10282-5
  • Scodari BT, Chacko S, Matsumura R, Jacobson NC. Using machine learning to forecast symptom changes among subclinical depression patients receiving stepped care or usual care. J Affect Disord. 2023;340:213–220. doi:10.1016/j.jad.2023.08.004
  • Puac-Polanco V, Ziobrowski HN, Ross EL, et al. Development of a model to predict antidepressant treatment response for depression among Veterans. Psychol Med. 2023;53(11):5001–5011. doi:10.1017/S0033291722001982
  • Salem H, Huynh T, Topolski N, et al. Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach. J Affect Disord. 2023;324:286–293. doi:10.1016/j.jad.2022.12.076
  • Abd-Alrazaq A, AlSaad R, Aziz S, et al. Wearable artificial intelligence for anxiety and depression: scoping review. J Med Internet Res. 2023;25:e42672.
  • Aziz S, Alsaad R, Abd-Alrazaq A, Ahmed A, Sheikh J. Performance of artificial intelligence in predicting future depression levels. Stud Health Technol Inform. 2023;305:452–455. doi:10.3233/SHTI230529
  • Abd-Alrazaq A, AlSaad R, Shuweihdi F, Ahmed A, Aziz S, Sheikh J. Systematic review and meta-analysis of performance of wearable artificial intelligence in detecting and predicting depression. NPJ Digit Med. 2023;6(1):84. doi:10.1038/s41746-023-00828-5
  • Ren B, Balkind EG, Pastro B, et al. Predicting states of elevated negative affect in adolescents from smartphone sensors: a novel personalized machine learning approach. Psychol Med. 2023;53(11):5146–5154. doi:10.1017/S0033291722002161
  • Lennon MJ, Harmer C. Machine learning prediction will be part of future treatment of depression. Aust N Z J Psychiatry. 2023;57(10):1316–1323. doi:10.1177/00048674231158267
  • Maslej MM, Kloiber S, Ghassemi M, Yu J, Hill SL. Out with AI, in with the psychiatrist: a preference for human-derived clinical decision support in depression care. Transl Psychiatry. 2023;13(1):210. doi:10.1038/s41398-023-02509-z
  • Devi R, Kanitkar K, Narendhar R, Sehmi K, Subramaniam K. A narrative review of the patient journey through the lens of non-communicable diseases in low- and middle-income countries. Adv Ther. 2020;37(12):4808–4830. doi:10.1007/s12325-020-01519-3
  • Xiao Y. The ”expert patient” approach for non-communicable disease management in low and middle income settings: when the reality confronts the rhetoric. Chronic Dis Transl Med. 2015;1(3):145–151. doi:10.1016/j.cdtm.2015.08.001
  • Bharatan T, Devi R, Huang PH, et al. A methodology for mapping the patient journey for noncommunicable diseases in low- and middle-income countries. J Healthc Leadersh. 2021;13:35–46. doi:10.2147/JHL.S288966
  • Paganin W. Viewpoint: difficult-to-treat depression versus treatment-resistant depression: a new integrative perspective for managing depression. Eur Psychiatry. 2023;66(1):e73. doi:10.1192/j.eurpsy.2023.2448
  • Camardese G, Mazza M, Zaninotto L, et al. Clinical correlates of difficult-to-treat depression: exploring an integrated day-care model of treatment. Nord J Psychiatry. 2016;70(1):45–52. doi:10.3109/08039488.2015.1048719
  • Pitanupong J, Aunjitsakul W. Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand. Qual Life Res. 2024;33(2):399–409. doi:10.1007/s11136-023-03527-6
  • Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M. Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study. Neuropsychiatr Dis Treat. 2016;12:2677–2687. doi:10.2147/NDT.S118593
  • Sun Y, Chen G, Wang L, et al. Perception of stigma and its associated factors among patients with major depressive disorder: a multicenter survey from an Asian population. Front Psychiatry. 2019;10:321. doi:10.3389/fpsyt.2019.00321
  • Lem WG, Kawata K, Oyama H. Exploring the impact of immersive virtual reality on depression knowledge and stigma reduction: a cross-over RCT fMRI study. Sci Rep. 2024;14(1):5193. doi:10.1038/s41598-024-55797-w
  • Shahwan S, Lau JH, Goh CMJ, et al. The potential impact of an anti-stigma intervention on mental health help-seeking attitudes among university students. BMC Psychiatry. 2020;20(1):562. doi:10.1186/s12888-020-02960-y
  • Zhu D, Lyu K. Anti-stigmatizing: a collaborative autoethnography on recovery from depression. Front Psychiatry. 2024;15:1360967. doi:10.3389/fpsyt.2024.1360967
  • Fusar-Poli P, Estrade A, Stanghellini G, et al. The lived experience of depression: a bottom-up review co-written by experts by experience and academics. World Psychiatry. 2023;22(3):352–365. doi:10.1002/wps.21111
  • Oliveira SE, Carvalho H, Esteves F. Internalized stigma and quality of life domains among people with mental illness: the mediating role of self-esteem. J Ment Health. 2016;25(1):55–61. doi:10.3109/09638237.2015.1124387
  • Parish AL, Gillis B, Anthamatten A. Pharmacotherapy for depression and anxiety in the primary care setting. J Nurse Pract. 2023;19(4):104556. doi:10.1016/j.nurpra.2023.104556
  • Lam RW, McIntosh D, Wang J, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. disease burden and principles of care. Can J Psychiatry. 2016;61(9):510–523. doi:10.1177/0706743716659416
  • Guo T, Xiang YT, Xiao L, et al. Measurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. Am J Psychiatry. 2015;172(10):1004–1013. doi:10.1176/appi.ajp.2015.14050652
  • Siniscalchi KA, Broome ME, Fish J, et al. Depression screening and measurement-based care in primary care. J Prim Care Community Health. 2020;11:2150132720931261. doi:10.1177/2150132720931261
  • Mayes TL, Deane AE, Aramburu H, Yagnik K, Trivedi MH. Improving identification and treatment outcomes of treatment-resistant depression through measurement-based care. Psychiatr Clin North Am. 2023;46(2):227–245. doi:10.1016/j.psc.2023.02.002
  • Balzen KM, Hensley JK, Nakonezny PA, Jones J, Kennard BD, Emslie GJ. Predicting remission from depression in youth receiving outpatient medication management. J Clin Psychiatry. 2023;84(4). doi:10.4088/JCP.22m14581
  • Cheung BS, Murphy JK, Michalak EE, et al. Barriers and facilitators to technology-enhanced measurement based care for depression among Canadian clinicians and patients: results of an online survey. J Affect Disord. 2023;320:1–6. doi:10.1016/j.jad.2022.09.055
  • Rea DO, Garber J. The effect of an office-based strategy on treatment outcome and adoption of measurement-based care into psychiatric treatment at a nonprofit, outpatient clinic. J Dr Nurs Pract. 2023. doi:10.1891/JDNP-2021-0042
  • Eder J, Dom G, Gorwood P, et al. Improving mental health care in depression: a call for action. Eur Psychiatry. 2023;66(1):e65. doi:10.1192/j.eurpsy.2023.2434
  • World Health Organization. WHO guideline: recommendations on digital interventions for health system strengthening. Geneva: World Health Organization; 2019. Available from: https://iris.who.int/bitstream/handle/10665/311941/9789241550505-eng.pdf?ua=1. Accessed June 10, 2024.
  • Frankish H, Boyce N, Horton R. Mental health for all: a global goal. Lancet. 2018;392(10157):1493–1494. doi:10.1016/S0140-6736(18)32271-2
  • Bavaresco R, Barbosa J, Vianna H, Buttenbender P, Dias L. Design and evaluation of a context-aware model based on psychophysiology. Comput Methods Programs Biomed. 2020;189:105299. doi:10.1016/j.cmpb.2019.105299
  • de Pablo G S, Studerus E, Vaquerizo-Serrano J, et al. Implementing precision psychiatry: a systematic review of individualized prediction models for clinical practice. Schizophr Bull. 2021;47(2):284–297. doi:10.1093/schbul/sbaa120
  • Chekroud AM, Bondar J, Delgadillo J, et al. The promise of machine learning in predicting treatment outcomes in psychiatry. World Psychiatry. 2021;20(2):154–170. doi:10.1002/wps.20882
  • Lin CC, Bai YM, Liu CY, et al. Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptoms. BMC Psychiatry. 2007;7:12. doi:10.1186/1471-244X-7-12
  • Li VW, Sahota J, Dev DK, et al. A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la dépression. Can J Psychiatry. 2024,Jul;69(7): 493–502. doi:10.1177/07067437241245331.
  • McCue M, Khatib R, Kabir C, et al. User-centered design of a digitally enabled care pathway in a large health system: qualitative interview study. JMIR Hum Factors. 2023;10:e42768.
  • Li N, Feng L, Hu J, et al. Using deeply time-series semantics to assess depressive symptoms based on clinical interview speech. Front Psychiatry. 2023;14:1104190. doi:10.3389/fpsyt.2023.1104190
  • Bugatti M, Owen J, Richardson Z, Rasmussen W, Newton D. Therapist engagement in measurement-based care: the association between client outcomes and therapist viewing frequency. Clin Psychol Psychother. 2023. doi:10.1002/cpp.2939
  • Aluttis C, Bishaw T, Frank MW. The workforce for health in a globalized context--global shortages and international migration. Glob Health Action. 2014;7:23611. doi:10.3402/gha.v7.23611
  • Dieleman J, Campbell M, Chapin A; Global Burden of Disease Health Financing Collaborator Network. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389(10083):1981–2004. doi:10.1016/S0140-6736(17)30874-7
  • Godoy L, Hodgkinson S, Robertson HA, et al. Increasing mental health engagement from primary care: the potential role of family navigation. Pediatrics. 2019;143(4). doi:10.1542/peds.2018-2418
  • Blease C, Locher C, Leon-Carlyle M, Doraiswamy M. Artificial intelligence and the future of psychiatry: qualitative findings from a global physician survey. Digit Health. 2020;6:2055207620968355. doi:10.1177/2055207620968355
  • Graham S, Depp C, Lee EE, et al. Artificial intelligence for mental health and mental illnesses: an overview. Curr Psychiatry Rep. 2019;21(11):116. doi:10.1007/s11920-019-1094-0
  • Sahoo JP, Narayan BN, Santi NS. The future of psychiatry with artificial intelligence: can the man-machine duo redefine the tenets? Consort Psychiatr. 2023;4(3):72–76. doi:10.17816/CP13626